Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Dr. Romain Lazor

Clinical trials sponsored by Dr. Romain Lazor, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Could a lung fibrosis drug stop nosebleeds in HHT? Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

Could a lung fibrosis drug stop nosebleeds in HHT?

Symptom relief Recruiting now

This study tests whether nintedanib, a drug already used for lung scarring, can reduce nosebleeds in people with hereditary hemorrhagic telangiectasia (HHT). About 48 adults with moderate to severe nosebleeds will take either nintedanib or a placebo twice daily for 16 weeks. The …

Phase 2 • Sponsor: Dr. Romain Lazor • Aim: Symptom relief

Last updated Jun 27, 2026 11:01 UTC